Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 22-Nov-24
Select bar for recommendation details.
Recommendations | 22-Nov-24 | |
---|---|---|
Buy | 7 | |
Outperform | 7 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 12 analysts offering 12 month price targets for Viking Therapeutics Inc have a median target of 114.00, with a high estimate of 164.00 and a low estimate of 95.00. The median estimate represents a 116.77% increase from the last price of 52.59.
High | 211.8% | 164.00 |
Med | 116.8% | 114.00 |
Low | 80.6% | 95.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 05, 2025.
Average growth rate | +0.10% |
Average growth rate | -27.34% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼